Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/26/2002US20020197688 Tobacco biomass utilization
12/26/2002US20020197685 Generation of preferential nucleotide sequences; obtain nucleotide sequences, remove phosphates, remove capping, incubate with nucleotide sequence adaptor, expose to polymerase, amplify recover nucleotide sequences
12/26/2002US20020197684 Ribozymes; for use as amplification tools in genetic engineering
12/26/2002US20020197682 Generation of preferentiaL polypetide in culture; obtain mutant aspergillus, culture, recover preferential poison polypeptide
12/26/2002US20020197680 54420, a novel human calcium channel
12/26/2002US20020197676 Novel chromophores/fluorophores and methods for using the same
12/26/2002US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002US20020197674 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002US20020197672 Comparative ligand mapping from MHC positive cells
12/26/2002US20020197670 Membrane associated progesterone receptor
12/26/2002US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis
12/26/2002US20020197666 Human chordin-related proteins and polynucleotides encoding them
12/26/2002US20020197657 Apoptosis-related compounds and their use
12/26/2002US20020197655 Antigen and monoclonal antibody which recognizes the antigen
12/26/2002US20020197645 Methods and compositions for directed microwave chemistry
12/26/2002US20020197643 Method and apparatus for producing biochips
12/26/2002US20020197642 Primer-mediated polynucleotide synthesis and manipulation techniques
12/26/2002US20020197639 Methods and products for analyzing nucleic acids based on methylation status
12/26/2002US20020197637 Extraction of nucleotide sequences from cells; obtain cells, incubate with lysis agent, extract and rcover
12/26/2002US20020197635 Information processing system using nucleotide sequence-related information
12/26/2002US20020197633 Nucleotide sequence for use in the detection and analysis of gene expression associated with age resistance
12/26/2002US20020197631 Multichamber device and uses thereof for processing of biological samples
12/26/2002US20020197627 Monitoring protein interaction and activities in cell; obtain mating yeast cells, mixing, incubate with modulate, evaluate cell activity
12/26/2002US20020197625 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection
12/26/2002US20020197624 Expression vector for use as tool in genome analysis
12/26/2002US20020197619 Assay methods and systems
12/26/2002US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool
12/26/2002US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/26/2002US20020197608 Detection of cancer in humans; obtain saliva sample, extract nucleotide sequences, detect nucleotide sequence mutation, evaluate for cancer
12/26/2002US20020197607 Nucleotide sequences for use in the detection of preferential microorganism in sample
12/26/2002US20020197605 Novel Polynucleotides
12/26/2002US20020197604 Extraction of preferential polypeptide from skin; obtain skin, remove preferential layer, extract preferential protein
12/26/2002US20020197602 Nucleic acid sequences and proteins associated with aging
12/26/2002US20020197596 Phosphoprotein target for insulin and its antagonists
12/26/2002US20020197417 Method for producing DNA chip, and DNA chip obtained thereby
12/26/2002US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells
12/26/2002US20020197277 Cell culture system for synthesis of infectious hepatitis C virus
12/26/2002US20020197269 Pharmaceutical composition for immunomodulation and preparation of vaccines
12/26/2002US20020197268 Allergen-containing milk for allergy treatment
12/26/2002US20020197266 Immunotherapy using interleukin 13 receptor subunit alpha 2
12/26/2002US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes
12/26/2002US20020197256 Combination therapy
12/26/2002US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/26/2002US20020197237 Adeno-associated virus vectors
12/26/2002US20020195345 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same
12/26/2002CA2391568A1 Collapsin response mediator protein-1
12/26/2002CA2391251A1 Metastasis-associated genes
12/26/2002CA2350328A1 Gene encoding oxalate decarboxylase from aspergillus phoenices
12/25/2002CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
12/25/2002CN1387574A Gene transfer method
12/25/2002CN1387573A Regulatory sequences and expression system functioning in filamentous fungi
12/25/2002CN1387572A Plant reglatory sequences for selective control of gene expression
12/25/2002CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity
12/25/2002CN1387569A Apoptin-associating protein
12/25/2002CN1387568A Modified ciliary neurotrophic factor, method of making and methods of use thereof
12/25/2002CN1387567A Conjugates between peptides and nucleic acid analog, such as PNA, LNA or morpholino
12/25/2002CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein
12/25/2002CN1387536A T2R-novel family of taste receptors
12/25/2002CN1387535A Novel muskelin and its application and producing method
12/25/2002CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002CN1387401A Use of haploid genomes for genetic diagnosis, modification and multiplication
12/25/2002CN1387399A Methods of producing target molecule in transgenic animal and purification of target molecule
12/25/2002CN1386865A Method for determining nucleic acid using control
12/25/2002CN1386860A Method for creating plant gene label system
12/25/2002CN1386859A Coding sequence of arisaema agglutinant protein and its application
12/25/2002CN1386858A 3 novel humanized tumor cell reproduction and tumor transfer suppressor genes
12/25/2002CN1386857A Humanized liver cell growth stimulating factor cDNA clone and sequence
12/25/2002CN1386856A Polypeptide-aconitase-8.8 and polynucleotide for coding it
12/25/2002CN1386855A Polypeptide-zinc metal endonuclease-41.25 and polynucleotide for coding it
12/25/2002CN1386853A Polypeptide-fatty acid enzyme-8.91 and polynucleotide for coding it
12/25/2002CN1386852A Polypeptide-pyrophosphatase-8.91 and polynucleotide for coding it
12/25/2002CN1386851A Polypeptide-human alcohol dehydrogenase III-51.37 and polynucleotide for coding it
12/25/2002CN1386850A Polypeptide-glyceraldehyde-3-phosphate dehydrogenase-8.91 and polyncleotide for coding it
12/25/2002CN1386849A Polypeptide-Ser/Thr kinase protein-51.37 and polynucleotide for coding it
12/25/2002CN1386762A Polypeptide-human macroprotein-51.37 and polynucleotide for coding it
12/25/2002CN1386761A Polypeptide-human reverse transcription associated protein-14.08 and polynucleotide for coding it
12/25/2002CN1386760A Polypeptide-olfactory receptor-10.78 and polynucleotide for coding it
12/25/2002CN1386759A Polypeptide-elastatinal-43.12 and polynucleotide for coding it
12/25/2002CN1386758A Polypeptide-human reverse transcription associated protein-15.07 and polynucleotide for coding it
12/25/2002CN1386757A Polypeptide-leukemia associated protein 29.81 and polynucleotide for coding it
12/25/2002CN1386756A Polypeptide-polypeptide chain surface receptor-38.28 and polynucleotide for coding it
12/25/2002CN1386755A Polypeptide-glucoprotein-11.22 and polynucleotide for coding it
12/25/2002CN1386753A Recombinant human endothelial growth arrestin with activity of inhibiting endothelial cell growth
12/25/2002CN1386751A Polypeptide-Pre-mRNA splicing factor-59.40 and polynucleotide for coding it
12/25/2002CN1386750A Process for preparing platelet factor 4 as genetically engineered medicine
12/25/2002CN1386749A Polypeptide-cotransporter-10.34 and polynucleotide for coding it
12/25/2002CN1386748A Polypeptide-ribosomal L3 protein-9.68 and polynucleotide for coding it
12/25/2002CN1386747A Polypeptide-histone H4-10.01 and polynucleotide for coding it
12/25/2002CN1386746A Polypeptide-thermal shock protein-10.67 and polynucleotide for coding it
12/25/2002CN1386548A Process for preparing transgenic compound particles of alkylated chitosan
12/25/2002CN1097039C Production of D-pantoic acid and D-pantothenic acid
12/24/2002US6498286 Germplasm containing an identifier nucleotide sequence and method for identifying germplasm
12/24/2002US6498245 Nucleic acid-immobilized substrate
12/24/2002US6498244 Adeno-associated virus capsid immunologic determinants
12/24/2002US6498243 Epimorphin antagonist and process for producing it
12/24/2002US6498242 Isolated nucleic acid fragment encoding adipic acid synthesizing enzymes selected from the group consisting of:an isolated nucleic acid molecule as set forth ; an isolated nucleic acid molecule that hybridizes with (a) under the